Literature DB >> 21807464

Cyto-reductive Surgery combined with Hyperthermic Intra-peritoneal Chemotherapy for Peritoneal Surface Malignancies: current treatment and results.

Antonio Sommariva1, Pierluigi Pilati, Carlo Riccardo Rossi.   

Abstract

Cyto-reductive Surgery (CS) combined with Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) as loco-regional treatment of Peritoneal Surface Malignancies (PSM) has increasingly gained acceptance in clinical practice. This review summarizes the more relevant studies on this topic. Indications, pre-operative work-up, technical aspects, outcome and future directions of this combined approach in the treatment of Peritoneal Surface Malignancies are discussed here and proposed in an informative and didactic manner.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21807464     DOI： 10.1016/j.ctrv.2011.07.001

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


  6 in total

1.  HIPEC as a risk factor for postoperative coagulopathy after cytoreductive surgery for peritoneal metastases.

Authors:  Antonio Sommariva; Marco Tonello; Emanuele Migliori; Elisa Pizzolato; Carola Cenzi; Marica Mirabella; Pierluigi Pilati
Journal:  Updates Surg       Date:  2022-08-06

2.  Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.

Authors:  Yvonne L B Klaver; Valery E P P Lemmens; Simon W Nienhuijs; Misha D P Luyer; Ignace H J T de Hingh
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

3.  Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysis.

Authors:  Marco Tonello; Andrea Barina; Federica Turchet; Ottavia De Simoni; Rita Alfieri; Boris Franzato; Mario Gruppo; Bruno Dengo; Davide Deffenu; Daniele Di Pasquale; Tania Fiore; Claudia Pietropaoli; Susanna Munaron; Giorgio Zanardo; Antonio Sommariva; Pierluigi Pilati
Journal:  Updates Surg       Date:  2020-11-04

Review 4.  Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.

Authors:  Maria Luisa Calabrò; Nayana Lazzari; Giulia Rigotto; Marco Tonello; Antonio Sommariva
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 5.  The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions.

Authors:  Madeleine C Strach; Sarah Sutherland; Lisa G Horvath; Kate Mahon
Journal:  Ther Adv Med Oncol       Date:  2022-07-23       Impact factor: 5.485

6.  Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.

Authors:  Peter H Cashin; Haile Mahteme; Wilhelm Graf; Henning Karlsson; Rolf Larsson; Peter Nygren
Journal:  BMC Cancer       Date:  2013-09-24       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.